← Back to Search

Virtual Reality for Substance Use Disorders (RENTS Trial)

N/A

Recruiting

Led By Brandon G Oberlin, PhD

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up study day visit; 30-day follow-up visit; 6-month follow-up visit.

Awards & highlights

RENTS Trial Summary

This trial will test if a VR intervention can reduce stimulant use and increase abstinence, with potential increases in future self-identification, future time perspective, and delayed rewards.

Who is the study for?

This trial is for adults over 18 who have been abstinent from stimulants for at least 14 days but no more than 6 months, are committed to recovery, and can understand English. They must be outpatients possibly taking psychotropic drugs for substance use disorder-related issues and sober from drugs/alcohol for at least 24 hours before study visits.Check my eligibility

What is being tested?

Researchers are testing a virtual reality intervention to see if it helps people with stimulant use disorders by reducing their drug use days, increasing abstinence periods, boosting future self-identification, enhancing the ability to wait for rewards, and improving perspective on the future.See study design

What are the potential side effects?

Since this trial involves virtual reality technology rather than medication or invasive procedures, side effects may include discomfort like dizziness or nausea related to VR usage but are generally expected to be minimal.

RENTS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ study day visit; 30-day follow-up visit; 6-month follow-up visit.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~study day visit; 30-day follow-up visit; 6-month follow-up visit.

This trial's timeline: 3 weeks for screening, Varies for treatment, and study day visit; 30-day follow-up visit; 6-month follow-up visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Delayed Reward Preference

Future Self-identification

Future Time Perspective

+3 more

RENTS Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Virtual RealityExperimental Treatment1 Intervention

Participants in this arm will receive the following interventions: Virtual Reality Park Virtual Reality Avatar

Group II: Treatment As UsualPlacebo Group1 Intervention

Participants in this arm will receive the following interventions: Virtual Reality Park

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Virtual Reality

2017

Completed Phase 3

~1630

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor

980 Previous Clinical Trials

981,674 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,643 Total Patients Enrolled

Brandon G Oberlin, PhDPrincipal InvestigatorIndiana University

3 Previous Clinical Trials

798 Total Patients Enrolled

Media Library

Virtual Reality Clinical Trial Eligibility Overview. Trial Name: NCT05835921 — N/A

Substance Use Disorder Research Study Groups: Virtual Reality, Treatment As Usual

Substance Use Disorder Clinical Trial 2023: Virtual Reality Highlights & Side Effects. Trial Name: NCT05835921 — N/A

Virtual Reality 2023 Treatment Timeline for Medical Study. Trial Name: NCT05835921 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any limits to the number of participants accepted in this research trial?

"Affirmative. Clinicaltrials.gov denotes that this clinical trial is scouring for volunteers, which was initially posted on March 28th 2023 and most recently updated April 19th 2023. The study requires 88 people to be recruited from 1 centre."

Answered by AI

Is enrollment available for this experiment in the present moment?

"According to the clinicaltrials.gov platform, this medical experiment is looking for participants and actively recruiting them. The study was initially advertised on March 28th 2023 and was last edited April 19th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Prospective Thinking in Early Recovery

Brandon G. Oberlin, PhD 2023. "Enhancing Prospective Thinking in Early Recovery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05835921.